Trial intelligence / Profile preview

Hydroxychloroquine pretreatment for pregnancy outcomes in women with polycystic ovary syndrome

ChiCTR1900026938Phase 4Recruiting

Sponsor
International Peace Maternity and Child Health Hospital
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of hydroxychloroquine in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoint: Live birth rate. Started Nov 2019; status: recruiting.

02

Drugs

hydroxychloroquine
03

Conditions

polycystic ovary syndrome (PCOS)female infertility

Beyond the preview

Go deeper on ChiCTR1900026938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call